{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00970580: Phase 1 Interventional Completed Non-Small Cell Lung Cancer
(2009)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03804944: Phase 2 Interventional Recruiting Breast Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
NCT00003414: Phase 3 Interventional Completed Graft Versus Host Disease
(1997)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01137552: Phase 1 Interventional Terminated Advanced Solid Tumors
(2010)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT00363714: Phase 1/Phase 2 Interventional Completed Age-Related Macular Degeneration
(2004)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:olisutrigine bromide [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02267642: Phase 2 Interventional Completed Psoriatic Arthritis
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02146313: Phase 1 Interventional Completed Pancreatic Neoplasms
(2014)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01018810: Phase 2 Interventional Terminated Psoriasis
(2009)
Source URL:
Class:
CONCEPT